Concepedia

M. Samarzjia

MS

Statistics

Publications

1

Citations

44

H-Index

1

Active since

2010

M. Samarzjia is an author specializing in health sciences, clinical injury, and cancer therapeutics.

Top concepts

Publications per year

2010–2010

1

Publications

1

Randomized phase III study (SPEAR) of picoplatin plus best supportive care (BSC) or BSC alone in patients (pts) with SCLC refractory or progressive within 6 months after first-line platinum-based chemotherapy.

Tudor–Eliade Ciuleanu, M. Samarzjia, Y. Demidchik et al. · Journal of Clinical Oncology · 2010 · 44 citations

, , +18

1–1 of 1